Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Zhao, Zhi-wei Zhang, Jing Zhang, Shun Zhang, Heng Zhang, Chi Zhao, Yang Chen, L. Luo, W. Tong, Chunde Li, Y. Niu, Pinan Liu (2020)
Loss of 5-Hydroxymethylcytosine as an Epigenetic Signature That Correlates With Poor Outcomes in Patients With MedulloblastomaFrontiers in Oncology, 11
(2017)
The role of 5-hydroxymethyl-cytosine in development, aging and age-related diseases
performed study concept and design. A.E.S., A.O., L.Y.
(2014)
The role of 5-hydroxymethylcytosine in human cancer, 356
I. Choi, M. Estecio, Y. Nagano, Do Kim, Jill White, James Yao, J. Issa, A. Rashid (2007)
Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)Modern Pathology, 20
P. Tomassetti, D. Campana, L. Piscitelli, R. Casadei, D. Santini, Francesca Nori, A. Morselli-Labate, R. Pezzilli, R. Corinaldesi (2005)
Endocrine pancreatic tumors: factors correlated with survival.Annals of oncology : official journal of the European Society for Medical Oncology, 16 11
O. Taşkın, C. Clarke, M. Erkan, S. Tsai, Douglas Evans, V. Adsay (2020)
Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication.Journal of gastrointestinal oncology, 11 3
Steigelman Kt (1951)
Tumors of the pancreas.The Journal of the American Osteopathic Association, 50 6
Zhihui Wang, Mulong Du, Qianyu Yuan, Yichen Guo, John Hutchinson, L. Su, Yinan Zheng, Jun Wang, L. Mucci, Xihong Lin, L. Hou, D. Christiani (2020)
Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancersNeoplasia (New York, N.Y.), 22
Peter Jones, S. Baylin (2002)
The fundamental role of epigenetic events in cancerNature Reviews Genetics, 3
Y. Jiao, C. Shi, B. Edil, R. Wilde, D. Klimstra, A. Maitra, R. Schulick, Laura Tang, elliot fishman, M. Choti, V. Velculescu, L. Diaz, B. Vogelstein, K. Kinzler, R. Hruban, N. Papadopoulos (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 331
Christopher Chapman, Christopher Mariani, Feng Wu, Katherine Meckel, F. Butun, A. Chuang, J. Madzo, M. Bissonnette, J. Kwon, L. Godley (2015)
TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancerScientific Reports, 5
Ken-ichi Takayama, A. Misawa, Takashi Suzuki, K. Takagi, Y. Hayashizaki, T. Fujimura, Y. Homma, Satoru Takahashi, T. Urano, S. Inoue (2015)
TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progressionNature Communications, 6
I. Marinoni, Anja Kurrer, E. Vassella, M. Dettmer, T. Rudolph, V. Banz, Fabio Hunger, Silvan Pasquinelli, E. Speel, A. Perren (2014)
Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.Gastroenterology, 146 2
M. Guo, Yaojun Peng, Aiai Gao, Chen Du, J. Herman (2019)
Epigenetic heterogeneity in cancerBiomarker Research, 7
C. Lian, Yufei Xu, C. Ceol, Feizhen Wu, A. Larson, K. Dresser, Wenqi Xu, Li Tan, Yeguang Hu, Q. Zhan, Chung-wei Lee, Di Hu, B. Lian, S. Kleffel, Yijun Yang, James Neiswender, Abraham Khorasani, Rui Fang, C. Lezcano, L. Duncan, R. Scolyer, J. Thompson, H. Kakavand, Y. Houvras, L. Zon, M. Mihm, U. Kaiser, T. Schatton, B. Woda, G. Murphy, Y. Shi (2012)
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of MelanomaCell, 150
D. Klimstra, I. Modlin, D. Coppola, R. Lloyd, S. Suster (2010)
The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging SystemsPancreas, 39
R. Chaligné, T. Popova, M. Mendoza-Parra, Mohamed-Ashick Saleem, D. Gentien, Kristen Ban, T. Piolot, O. Leroy, O. Mariani, H. Gronemeyer, A. Vincent-Salomon, M. Stern, E. Heard (2015)
The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancerGenome Research, 25
Michael Booth, Miguel Branco, G. Ficz, David Oxley, Felix Krueger, Wolf Reik, Shankar Balasubramanian (2012)
Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base ResolutionScience, 336
Ken-ichi Takayama, A. Misawa, Takashi Suzuki, K. Takagi, Y. Hayashizaki, T. Fujimura, Y. Homma, Satoru Takahashi, T. Urano, S. Inoue (2015)
TET 2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression
S. Partelli, F. Giannone, M. Lena, F. Muffatti, V. Andreasi, S. Crippa, D. Tamburrino, G. Zamboni, C. Rubini, C. Doglioni, M. Falconi (2019)
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic SpecimensNeuroendocrinology, 109
M. Griffith, O. Griffith (2014)
COSMIC (Catalogue of Somatic Mutations in Cancer)Dictionary of Bioinformatics and Computational Biology
A. Scarpa, D. Chang, K. Nones, V. Corbo, A. Patch, Peter Bailey, R. Lawlor, A. Johns, David Miller, A. Mafficini, B. Rusev, M. Scardoni, D. Antonello, S. Barbi, K. Sikora, S. Cingarlini, C. Vicentini, S. McKay, M. Quinn, T. Bruxner, Angelika Christ, Ivon Harliwong, S. Idrisoglu, S. McLean, C. Nourse, Ehsan Nourbakhsh, P. Wilson, M. Anderson, L. Fink, F. Newell, N. Waddell, O. Holmes, S. Kazakoff, C. Leonard, S. Wood, Qinying Xu, Shivashankar Nagaraj, E. Amato, I. Dalai, S. Bersani, I. Cataldo, A. Tos, P. Capelli, M. Davi’, L. Landoni, A. Malpaga, Marco Miotto, V. Whitehall, B. Leggett, J. Harris, Jonathan Harris, Marc Jones, J. Humphris, L. Chantrill, V. Chin, A. Nagrial, M. Pajic, C. Scarlett, Andreia Pinho, I. Rooman, C. Toon, Jianmin Wu, M. Pinese, M. Cowley, A. Barbour, A. Mawson, Emily Humphrey, E. Colvin, A. Chou, Jessica Lovell, N. Jamieson, F. Duthie, M. Gingras, W. Fisher, Rebecca Dagg, L. Lau, Michael Lee, H. Pickett, R. Reddel, J. Samra, J. Kench, N. Merrett, K. Epari, N. Nguyen, N. Zeps, M. Falconi, M. Simbolo, G. Butturini, G. Buren, S. Partelli, M. Fassan, K. Khanna, A. Gill, D. Wheeler, R. Gibbs, E. Musgrove, C. Bassi, G. Tortora, P. Pederzoli, J. Pearson, N. Waddell, A. Biankin, S. Grimmond (2017)
Whole-genome landscape of pancreatic neuroendocrine tumoursNature, 543
Jianjiong Gao, B. Aksoy, U. Dogrusoz, Gideon Dresdner, Benjamin Gross, S. Sumer, Yichao Sun, A. Jacobsen, Rileen Sinha, E. Larsson, E. Cerami, C. Sander, N. Schultz (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 6
V. Lakis, R. Lawlor, F. Newell, A. Patch, A. Mafficini, A. Sadanandam, L. Koufariotis, R. Johnston, C. Leonard, S. Wood, B. Rusev, V. Corbo, C. Luchini, S. Cingarlini, L. Landoni, R. Salvia, M. Milella, D. Chang, Peter Bailey, N. Jamieson, F. Duthie, M. Gingras, D. Muzny, D. Wheeler, R. Gibbs, M. Milione, Lorraine Hermann, Lorraine Hermann, L. Chantrill, P. Timpson, A. Chou, M. Pajic, Angela Murphy, Tanya Dwarte, David Hermann, C. Vennin, Thomas Cox, Brooke Pereira, Shona Ritchie, Daniel Reed, C. Chambers, Xanthe Metcalf, M. Nobis, Pamela Xu, Pamela Mukhopadhyay, V. Addala, S. Kazakoff, O. Holmes, Qinying Xu, Oliver Hofmann, Jaswinder High, J. Samra, Nick Pavlakis, J. Arena, H. High, Ray Das, R. Asghari, N. Merrett, Darren Pavey, Amitabha Das, Peter O’Connnor, P. Cosman, Kasim Ismail, Chelsie O’Connnor, Alina Spigellman, A. Stoita, David Williams, Allan Spigellman, Vincent Kirk, Vincent Lam, Duncan McLeod, Judy Kirk, James Goodwin, J. Kench, Peter Grimison, C. Sandroussi, Annabel Goodwin, R. Andrews, R. Mead, Katherine Tucker, Lesley Andrews, Michael Fletcher, Michael Texler, Cindy Forest, Mo Ballal, David Fletcher, N. Zeps, Nan Worthley, Nan Nguyen, Andrew Ruszkiewicz, C. Worthley, John Papangelis, John Chen, M. Brooke-Smith, V. Papangelis, Andrew Clouston, Andrew Hodgkin, Andrew Barbour, Thomas O’Rourke, Jonathan Fawcett, Kellee Slater, M. Hatzifotis, Peter Hodgkinson, M. Nikfarjam, James Wolfgang, J. Eshleman, R. Hruban, Christopher Wolfgang, Judith Dixon, Maria An, M. Scardoni, Claudio Bassi, Sonia Grimaldi, C. Cantù, G. Bonizzato, S. Bersani, D. Antonello, L. Piredda, Nicola Sperandio, S. Barbi, Paola Merlini, P. Pederzoli, J. Samra, A. Gill, A. Johns, J. Pearson, A. Biankin, S. Grimmond, N. Waddell, K. Nones, A. Scarpa (2021)
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical associationCommunications Biology, 4
Joo-Kyung Park, W. Paik, K. Lee, J. Ryu, S. Lee, Yong-Tae Kim (2017)
DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumorsOncotarget, 8
J. Herman, S. Baylin (2003)
Gene silencing in cancer in association with promoter hypermethylation.The New England journal of medicine, 349 21
Yi-Chen Wu, Z. Ling (2014)
The role of TET family proteins and 5-hydroxymethylcytosine in human tumors.Histology and histopathology, 29 8
A. Eden, F. Gaudet, A. Waghmare, R. Jaenisch (2003)
Chromosomal Instability and Tumors Promoted by DNA HypomethylationScience, 300
Z. Cai, J. Zhang, Y. He, L. Xia, X. Dong, G. Chen, Y. Zhou, X. Hu, S. Zhong, Y. Wang, H. Chen, D. Xie, X. Liu, J. Liu (2021)
Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinomaESMO Open, 6
B. Lawrence, C. Blenkiron, K. Parker, P. Tsai, Sandra Fitzgerald, P. Shields, T. Robb, M. Yeong, N. Kramer, S. James, M. Black, V. Fan, Nooriyah Poonawala, Patrick Yap, E. Coats, B. Woodhouse, R. Ramsaroop, M. Yozu, B. Robinson, K. Henare, J. Koea, P. Johnston, Richard Carroll, S. Connor, H. Morrin, M. Elston, C. Jackson, Papaarangi Reid, J. Windsor, A. MacCormick, R. Babor, Adam Bartlett, D. Damianovich, N. Knowlton, S. Grimmond, M. Findlay, C. Print (2017)
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancerNPJ Genomic Medicine, 3
D. Man, Jingjing Wu, Zhangguo Shen, Xiaoyi Zhu (2018)
Prognosis of patients with neuroendocrine tumor: a SEER database analysisCancer Management and Research, 10
Kohei Fujikura, Zainab Alruwaii, Michael Haffner, M. Trujillo, Nicholas Roberts, Seung‐Mo Hong, A. Macgregor-Das, M. Goggins, Sujayita Roy, A. Meeker, D. Ding, M. Wright, Jin He, R. Hruban, L. Wood (2021)
Downregulation of 5‐hydroxymethylcytosine is an early event in pancreatic tumorigenesisThe Journal of Pathology, 254
Dysregulation of epigenetic mechanisms, reflected by loss of expression of 5-hydroxymethylcytosine (5-hmC) is being increasingly recognized as a marker of aggressive behavior in several neoplasms; however, the role of such epigenetic modifiers in pancreatic neuroendocrine tumors (PanNETs) has not been studied. Annotated cohort of 60 PanNETs was evaluated for 5-hmC expression using immunohistochemistry. Univariable and multivariable analyses were performed. To determine intratumor heterogeneity of 5-hmC expression, 26 additional synchronous metastatic deposits of PanNETs from 8 patients were evaluated for 5-hmC expression. 5-hmC level showed significant association with the presence of distant metastases (P=0.02), female sex (P=0.04), and Ki-67 proliferation index (P=0.002). A multivariate model created using the stepwise logistic regression analysis showed the presence of nodal metastases (odds ratio=6.15), lymphovascular invasion (odds ratio=4.07) and lack of 5-hmC expression (odds ratio=5.34) were predictive of the risk of distant metastasis in PanNETs with a c-statistic of 0.845. Epigenetic intratumoral heterogeneity of 5-hmC expression was seen in 37.5% cases (3/8). Our work provides evidence that epigenetic regulators are involved in the pathobiology of PanNETs and immunohistochemical analysis of 5-hmC may be able to refine prognostic evaluation of these tumors.
Applied Immunohistochemistry – Wolters Kluwer Health
Published: Feb 26, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.